TY - JOUR AU - Bag, Subhendu Sekhar AU - Sinha, Sayantan AU - Saito, Isao PY - 2020 TI - A Systematic Review of the Efficacy and Safety of Favipiravir (Avigan) for the Treatment of Novel COVID-19 Infections JF - Medical Research Archives; Vol 8 No 8 (2020): Vol.8 Issue 8, August 2020 DO - 10.18103/mra.v8i8.2210 KW - N2 - Since the emergence of SARS-CoV-2 infection in Wuhan, China, in December 2019, the spread has caused COVID19 disease in over 8.1 million people and more than 439 thousand deaths across the globe as on 16th June 2020. Absence of any particular cure or vaccine lead the health care system to treat the patients with the existing potential antiviral drugs. Recently, Favipiravir, a potential RdRp inhibitor of SARS-COV-2 sheds the ray of hope for treating COVID-19 patients efficiently. UR - https://esmed.org/MRA/mra/article/view/2210